p53 pathway dysfunction in AML: beyond TP53 mutations

被引：5
|
作者：
Post, Sean M. [1 ]
Kornblau, Steven M. [1 ]
Quintas-Cardama, Alfonso [1 ]
机构：
[1] TCR2 Therapeut, Cambridge, MA 02142 USA
来源：
ONCOTARGET | 2017年 / 8卷 / 65期
关键词：
TP53; Mdm2; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADULTS;
D O I：
10.18632/oncotarget.22713
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：108288 / 108289
页数：2
相关论文
共 50 条
  • [41] De Novo Myelodysplastic Syndromes With Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression
    Loghavi, Sanam
    Al-Lbraheemi, Alyaa
    Zuo, Zhuang
    Wang, Sa
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Yin, C. Cameron
    Miranda, Roberto
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Khoury, Joseph
    LABORATORY INVESTIGATION, 2015, 95 : 361A - 361A
  • [42] TP53 GENE-MUTATIONS AND P53 PROTEIN IMMUNOREACTIVITY IN MALIGNANT AND PREMALIGNANT BARRETTS-ESOPHAGUS
    HAMELIN, R
    FLEJOU, JF
    MUZEAU, F
    POTET, F
    LAURENTPUIG, P
    FEKETE, F
    THOMAS, G
    GASTROENTEROLOGY, 1994, 107 (04) : 1012 - 1018
  • [43] TP53 GENE-MUTATIONS AND P53 PROTEIN IMMUNOREACTIVITY IN MALIGNANT AND PREMALIGNANT BARRETTS-ESOPHAGUS
    FLEJOU, JF
    MUZEAU, F
    HAMELIN, R
    LAURENTPUIG, P
    POTET, F
    THOMAS, G
    GASTROENTEROLOGY, 1994, 106 (04) : A386 - A386
  • [44] TP53 mutations, p53 protein accumulation, and Ki 67 immunostaining have no prognostic value in oligodendrogliomas
    Hagel, C
    Krog, B
    Laas, R
    Stavrou, D
    BRAIN PATHOLOGY, 1997, 7 (04) : 1164 - 1164
  • [45] p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection
    Kasprzak, Aldona
    Adamek, Agnieszka
    Przybyszewska, Wieslawa
    Czajka, Arkadiusz
    Olejniczak, Karolina
    Juszczyk, Jacek
    Biczysko, Wieslawa
    Zabel, Maciej
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (01) : 35 - 42
  • [46] De Novo Myelodysplastic Syndromes With Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression
    Loghavi, Sanam
    Al-Ibraheemi, Alyaa
    Zuo, Zhuang
    Wang, Sa
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Yin, C. Cameron
    Miranda, Roberto
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Khoury, Joseph
    MODERN PATHOLOGY, 2015, 28 : 361A - 361A
  • [47] Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network
    Rossi, Marianna
    Croci, Giorgio
    Boveri, Emanuela
    Gianelli, Umberto
    Ponzoni, Maurilio
    Giordano, Laura
    Ubezio, Marta
    Travaglino, Erica
    Morabito, Lucio
    Milanesi, Chiara
    Saba, Elena
    Borin, Lorenza
    Bernardi, Massimo
    Santini, Valeria
    Voso, Maria Teresa
    Fenu, Susanna
    Orazi, Attilio
    Santoro, Armando
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    Della Porta, Matteo Giovanni
    BLOOD, 2017, 130
  • [48] Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
    Marcel, V.
    Fernandes, K.
    Terrier, O.
    Lane, D. P.
    Bourdon, J-C
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1377 - 1387
  • [49] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1034 - 1035
  • [50] Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
    V Marcel
    K Fernandes
    O Terrier
    D P Lane
    J-C Bourdon
    Cell Death & Differentiation, 2014, 21 : 1377 - 1387
12345